We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
201
AIA Group
Hong Kong
– -$1.15M -3,630 Closed
YIH
202
Y-Intercept (HK)
Hong Kong
– -$1.12M -3,540 Closed
AA
203
AlphaCentric Advisors
Puerto Rico
– -$1.11M -3,500 Closed
Jane Street
204
Jane Street
New York
– -$1.09M -3,456 Closed
JFG
205
Jefferies Financial Group
New York
– -$1.09M -3,436 Closed
ProShare Advisors
206
ProShare Advisors
Maryland
– -$1.08M -3,406 Closed
PAMP
207
Polar Asset Management Partners
Ontario, Canada
– -$981K -3,100 Closed
BCM
208
BCK Capital Management
Connecticut
– -$950K -3,000 Closed
Canada Life
209
Canada Life
Manitoba, Canada
– -$941K -2,994 Closed
MAP
210
Moody Aldrich Partners
Massachusetts
– -$934K -2,951 Closed
OAM
211
Oppenheimer Asset Management
New York
– -$900K -2,845 Closed
MSRPS
212
Maryland State Retirement & Pension System
Maryland
– -$889K -2,810 Closed
Group One Trading
213
Group One Trading
Illinois
– -$837K -2,644 Closed
MAM
214
Meeder Asset Management
Ohio
– -$827K -2,613 Closed
CL
215
CSS LLC
Illinois
– -$823K -2,600 Closed
SC
216
Sagefield Capital
Texas
– -$823K -2,600 Closed
Walleye Trading
217
Walleye Trading
New York
– -$800K -2,528 Closed
KCM
218
KRS Capital Management
Michigan
– -$748K -2,364 Closed
EFM
219
E Fund Management
China
– -$740K -2,338 Closed
TC
220
Torno Capital
Massachusetts
– -$728K -2,300 Closed
KOCAA
221
Knights of Columbus Asset Advisors
Connecticut
– -$709K -2,241 Closed
SAM
222
Sectoral Asset Management
Quebec, Canada
– -$707K -2,235 Closed
SCA
223
Snowden Capital Advisors
New York
– -$706K -2,231 Closed
Blackstone Inc
224
Blackstone Inc
New York
– -$699K -2,207 Closed
DAM
225
DLD Asset Management
New York
– -$696K -2,200 Closed
7 8
9
10 11

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.